In Vitro Fertilization Market Cost and Sales Projection, Growth Statistics, Top Companies Profile, Business Overview, Size Estimation and Global Market Trends By 2023

In Vitro Fertilization Market Cost and Sales Projection, Growth Statistics, Top Companies Profile, Business Overview, Size Estimation and Global Market Trends By 2023

“In Vitro Fertilization Market”
In Vitro Fertilization Market Analysis By Size, Share, Key Players, Trends, Insights, Dynamics, Future Outlook, Applications and Segmentation, Forecast to 2023

In Vitro Fertilization Market Share, Growth And Trends Analysis By Type (Intrauterine Insemination, Intracytoplasmic Sperm Injection, Ivf Using Donor Eggs),By Devices (Imaging Systems, Sperm Separation System, Ovum Aspiration Pump, Micromanipulator, Cryosystem) By Reagents (Embryo Culture Media, Cryopreservation Media, Sperm Processing Media, Ovum Processing Media), By End Users (Clinical Research Institutes, Fertility Clinics, Hospitals), Global Forecast To 2023

The Global In-Vitro Fertilization (IVF) Market Size and Share to project lucrative CAGR over the assessment period (2016-2023), According to Market Research Future (MRFR). In Vitro fertilization (IVF) involves the collection of mature eggs from ovaries of females which are fertilized by sperm in a laboratory, the embryo formed is then transplanted back to the female to aid conception or prevent genetic diseases. IVF is a time tested and effective assisted reproductive technology and has resulted in almost 200,000 births to date.

The greater flexibility afforded by IVF, such as the selection of the source or donor of eggs, sperm, and gestational carrier, is driving a large market. The global in-vitro fertilization market is expanding owing to the rising incidence of infertility.

Attractive advantages of IVF such as pregnancy at an advanced age, or even after menopause, the increase of age during marriage owing to social factors such as education, urbanization, and women empowerment is driving a large market. Additional factors fostering the market growth are the growing per capita income, a growing number of IVF clinics, acceptance of IVF by the society, and the reduction in the taboo against it.

Request Free Sample Copy at:

Vitro Fertilization Market Segmentation

MRFR has segmented the in vitro fertilization market into four dynamics to widen the scope of understanding,

  • By Product, the in vitro fertilization market is segmented into: Devices (Imaging systems, Sperm separation system, Ovum aspiration pump, Cerosystem, Micromanipulator), Reagents (Embryo culture media, Sperm processing media, Cryopreservation media, Ovum processing media) among others.
  • By Type, the in vitro fertilization market is segmented into: Intrauterine insemination, In-vitro fertilization, Intracytoplasmic sperm injection, IVF using donor eggs, among others.
  • By, the in vitro fertilization market is segmented into End-user: Fertility Clinics, Hospitals, Clinical Research Centers, and others.
  • By Regions, the in vitro fertilization market is segmented into: Europe, North America, Asia Pacific, and the Rest-of-the-World.

In Vitro Fertilization Market Regional Analysis:

North America dominates the global in vitro fertilization market owing to large per capita income, the presence of huge numbers of fertility clinics, and the growing incidence of infertility. According to the National Center for Chronic Disease Prevention and Health Promotion (CDC), almost 6% of women in the U.S. are infertile after one year of trying. The CDC also estimates that in 2017, 284,385 IVF cycles were performed in the U.S., causing 68,908 live births. The growing number of embryo banking facilities and the explosive adoption of the technology is driving a large growth. According to data from 2018, the use of IVF has doubled over the past decade, and almost 1.7% of all births in the U.S. per year are conceived through IVF.

The European IVF market is dominated by France, Germany, and the U.K. The proliferating fertility clinics and large per capita income in the region is driving large market demand.

The Asia Pacific in vitro fertilization market is projected to expand at a faster rate owing to the shift of modernization towards the developing nations. The large population of Asia Pacific and rising industrialization is driving a large market. Japan and South Korea have a disproportionate share of the Asia Pacific in vitro fertilization market owing to their large healthcare expenditure and increasing age of marriage. However, China is expected to drive the fastest growth rate owing to economic development and growing per capita income. Infertility affects between 3.9 to 16.8% of reproductive-aged couples in India, according to World Health Organization estimates.

The Middle East and Africa market are constrained by the poor healthcare infrastructure of the Saharan African nations and the social taboo in the Gulf nations. However, the situation is projected to change in the coming years.

In Vitro Fertilization Market Competitive Landscape

The IVF market is consolidated and yields a premium on products owing to low competition. Players rely on collaboration and partnerships with large hospitals so as to expose their products to physicians and patients alike.

Manufacturers of in vitro fertilization provide customized products after appropriate modifications to ensure high quality and consistency of the product. They are also increasingly investing in R&D activities and upgrading their laboratories using state of the art products, strong sales network while focusing on lead generation strategies.

Major Players:

Players leading the global in vitro fertilization industry include Thermo Fisher Scientific, Oxford Gene Technology, Cooper Surgical Fertility, Genea Biomedix, Cook Medical, INVO Bioscience, Merck KGaA, Irvine Scientific, Genea Limited, Vitrolife, among others.

In Vitro Fertilization Industry/ Innovation/ Related News:

Oral dydrogesterone may become a new treatment of choice for women undergoing IVF treatment. The latest results of the Lotus I study, involving more than 1,000 women demonstrated similar efficacy & tolerability to micronized vaginal progesterone (MVP). The current standard of care used to prepare the uterus lining for IVF.

Lotus I, was a Phase III randomized controlled clinical study that evaluated the effects of oral dydrogesterone in luteal support in IVF. The findings of the Lotus I study demonstrated clinical evidence in support of Oral dydrogesterone and tolerance compared to MVP.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India